Calzada (ASX:CZD) has announced the resignation of an independent director, while GI Dynamics (ASX:GID) and pSivida (ASX:PVA) have selected new members for their own boards. [ + ]

The Australian Museum Eureka Prizes last night celebrated 25 years of rewarding outstanding contributions to Australian science. [ + ]

In November 2013, Flinders University officially opened its Clean Technology Laboratory - a $1.1 million initiative to research and develop sustainable manufacturing methods. [ + ]

Researchers from Pennsylvania State University have demonstrated an acoustofluidic pump powered by a piezoelectric transducer the size of a coin.  [ + ]

Analysis of safety data from the first two cohorts involved in Invion's (ASX:IVX) trial of INV103 in lupus has given the company the confidence to step up the dose for the next stage. [ + ]

Singaporean scientists have invented a technique to detect malaria within minutes from a single drop of blood. The method was developed by the Singapore-MIT Alliance for Research and Technology (SMART) in collaboration with Nanyang Technological University (NTU).

Former CSL (ASX:CSL) executive Peter Turvey has been named a Viralytics (ASX:VLA) non-executive director, while Viralytics CEO Malcolm McColl will take the role of managing director. [ + ]

ResMed (ASX:RMD) has declared a truce in its copyright infringement war with Taiwan's APEX Medical, signing a confidential settlement. [ + ]

Phylogica and the UQ's Institute for Molecular Bioscience have picked up grant funding for a project to screen for potential new antimetastatic drugs. [ + ]

Despite how hard we may try to scrub ourselves clean with antibacterial soap, it appears that humans are more tightly bound to our surrounding microbes than we thought. [ + ]

Alchemia's (ASX:ACL) share of the profits from sales of anti-coagulant generic fondaparinux declined in FY14, but the company expects business to pick up from 2015. [ + ]

​The newly formed Medical Research Future Fund (MRFF) Action Group is advocating for what it claims to be the most important initiative in Australian medical research in generations. [ + ]

RMIT University has opened its new MicroNano Research Facility (MNRF) - a $30 million, 1200 m² building that will drive cutting-edge advances in micro- and nanotechnologies, supporting projects that span across the traditional disciplines of physics, chemistry, engineering, biology and medicine. [ + ]

The AFL has added Regeneus (ASX:RGS) HiQCell to a list of approved treatments for injuries including impact-related osteoarthritis and tendonitis. [ + ]

Vaxxas has been selected as a 2015 Technology Pioneer by the World Economic Forum for its patch-based vaccine delivery technology. [ + ]